Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis

By Roblin David   Yosipovitch Gil   Boyce Brent   Robinson John   Sandy James   Mainero Valentina   Wickramasinghe Ro   Anand Uma   Anand Praveen  

Acta Dermato-Venereologica, Vol. 95, Iss. 5, 2015-05 ,pp. : 542-548

Medical Journals Limited

Access to resources Recommend Favorite

Hypercalcaemia and Hypercalciuria after Topical Treatment of Psoriasis with Excessive Amounts of Calcipotriol

By Georgiou S   Tsambaos D  

Acta Dermato-Venereologica, Vol. 79, Iss. 1, 1999-03 ,pp. : 86-86

Medical Journals Limited

Access to resources Recommend Favorite

Exfoliative Dermatitis after Long-term Methotrexate Treatment of Severe Psoriasis

By Peters Thorsten   Theile-Ochel Susanne   Chemnitz Jens   Söhngen Dietmar   Hunzelmann Nicolas   Scharffetter-Kochanek Karin  

Acta Dermato-Venereologica, Vol. 79, Iss. 5, 1999-08 ,pp. : 391-392

Medical Journals Limited

Access to resources Recommend Favorite

Expression of p53 Protein Before and After PUVA Treatment in Psoriasis

By Hannuksela-Svahn Anna   Pääkkö Paavo   Autio Pekka   Reunala Timo   Karvonen Jaakko   Vähäkangas Kirsi  

Acta Dermato-Venereologica, Vol. 79, Iss. 3, 1999-05 ,pp. : 195-199

Medical Journals Limited

Access to resources Recommend Favorite

Changes in Quality of Life in Persons with Eczema and Psoriasis After Treatment in Departments of Dermatology

By Wahl Astrid K.   Mørk Cato   Lillehol Bodil Mørk   Myrdal Anne M.   Helland Svein   Hanestad Berit R.   Moum Torbjørn  

Acta Dermato-Venereologica, Vol. 86, Iss. 3, 2006-05 ,pp. : 198-201

Medical Journals Limited

Access to resources Recommend Favorite